- Home
- RFIL vs NTRB Comparison
RFIL vs NTRB Comparison
Compare RFIL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RFIL | NTRB |
|---|---|---|
| Founded | 1979 | 2016 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 72.6M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RFIL | NTRB |
|---|---|---|
| Price | $7.61 | $6.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 165.9K | 33.6K |
| Earning Date | 09-14-2026 | 12-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $55,325,000.00 | $2,036,651.00 |
| Revenue This Year | $9.73 | $4,584.65 |
| Revenue Next Year | $10.06 | $89.09 |
| P/E Ratio | $39.50 | ★ N/A |
| Revenue Growth | ★ 10.22 | N/A |
| 52 Week Low | $5.54 | $2.80 |
| 52 Week High | $22.30 | $9.19 |
Technical Indicators
Market Signals| Indicator | RFIL | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 49.17 |
| Support Level | $6.61 | $5.68 |
| Resistance Level | $8.63 | $9.19 |
| Average True Range (ATR) | 0.41 | 0.44 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 71.62 | 52.17 |
Price Performance
Historical ComparisonAbout RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.